Registry for organ transplant recipients and donors at the University of Minnesota
Official title: University of Minnesota Transplant Registry
Run by University of Minnesota · NCT01062581 · Data updated 2026-11-12
This study is collecting information from organ transplant recipients and donors to help improve the understanding and management of transplant outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | University of Minnesota Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Status | Recruiting |
| Started | March 1997 |
| Main results expected | January 2050 |
| Study ends | January 2050 |
| Registry record updated | April 20, 2026 |
| Trial ID | NCT01062581 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are individuals who have received a transplanted organ or have donated an organ at the University of Minnesota.
✕Probably not a fit
Patients who received transplants or donated organs at institutions other than the University of Minnesota will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The University of Minnesota Transplant Registry (UMTR) is an observational registry that collects and maintains core research data related to organ transplantation. It aims to provide essential outcomes data and background information to facilitate outcomes management research in solid organ transplantation and advanced lung disease. The registry supports innovative research by utilizing existing program-specific databases for various types of transplants, including liver, kidney, heart, and lung. This ongoing registration of transplant cases is crucial for advancing the understanding and management of transplant outcomes.
Why it matters
Potential benefit: If successful, this registry could enhance the understanding of transplant outcomes and improve patient care in organ transplantation.
How similar studies have gone: Other transplant registries have shown success in improving outcomes and advancing research in organ transplantation, indicating that this approach is well-established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Received a transplanted organ at the University of Minnesota * Living donor who donates an organ at the University of Minnesota Exclusion Criteria: * Did not receive a transplant at the University of Minnesota * Did not donate an organ at the University of Minnesota
Where it's running
-
University of Minnesota Transplant Information Services
Minneapolis, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Arthur Matas, MD — University of Minnesota
- Study coordinator: Arthur Matas, MD
- Email: matas001@umn.edu
- Phone: (612) 625-6460
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preoperative sensory modulation room to reduce pain, anxiety, and improve sleep for living kidney donors and recipients
The team will try a short preoperative session in a sensory modulation room to see if it lowers postoperative pain, reduces anxiety, and improves sleep for adult living kidney donors and transplant recipients.
-
Information-assisted support for people considering living kidney donation
This program will try an information-assisted approach to improve knowledge, boost decision-making confidence, and reduce decisional conflict for people considering living kidney donation.
-
Prospective blood collection to detect donor-derived cell-free DNA after kidney transplant
This project will collect blood from adults who had a kidney transplant to try a blood test that detects donor-derived cell-free DNA to check the transplanted organ.
-
RSV vaccine safety and immune response in lung transplant patients vs. healthy adults
This study tests how well the RSV vaccine works and how safe it is in people who have had a lung transplant compared with healthy adults.
-
Letermovir plus standard antiviral to clear CMV in lung transplant recipients
This will test whether adding letermovir to usual antiviral treatment helps clear CMV in lung transplant recipients with active infection by week 3.
-
UV-treated, antiviral-protected lungs from Hepatitis B–positive donors for transplant
This will try using lungs from hepatitis B–positive donors that are treated with UV light during ex vivo lung perfusion plus post-transplant antiviral medicines to see if they can be safely transplanted into HBV-negative lung transplant candidates.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.